Wegovy® is a once-weekly weight loss injection designed to help suppress appetite, with patients achieving an average weight loss of 15%. It contains the active ingredient Semaglutide and is delivered via a pre-filled pen. Wegovy is simple to use, with very small needles, making it relatively painless and easy to adapt to.
Wegovy, containing Semaglutide, is prescribed for adults with obesity. It was approved in the USA in 2021 and became available in the UK in September 2023.
The injection can be administered in the abdomen, thigh, or upper arm, at any time of day, with or without food. For optimal effectiveness, it’s recommended to use it on the same day each week.
With your first order, you’ll receive clear instructions on how to use Wegovy, and additional resources are available on the official Wegovy website.